Lorusso, D.Xiang, Y.Hasegawa, K.Scambia, G.Galves, M. H. LeivaElias, P. RamosAcevedo, A.Vizkeleti, J.Gomes, A. J. P. D. S.Mejia, F. ContrerasReiss, A.Ayhan, A.Lee, J. Y.Saevets, V.Zagouri, F.Li, K.Yamada, K. UssuiToker, S.Pignata, S.Duska, L. R.2024-05-202024-05-2020230923-7534http://hdl.handle.net/11727/12120https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2823%2904176-5enginfo:eu-repo/semantics/openAccessPembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer: A Randomized, Doubleblind, Phase III ENGOT-Cx11/GOG-3047/KEYNOTE-A18 StudyconferenceObject34Supplement 2S1279S12800010874802035191569-8041